Business
Investor buzz around cannabis stocks with new treatments – Sydney Morning Herald
Cannabis startups get down to business as treatments normalised and some small stocks are winning big name backers.
Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent.
Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the nation’s special access scheme for cannabis products.
Thorney bumped its stake after a private placement of 37 million shares at 5.4c each.
“The str…
-
Business13 hours agoWarning! These ASX 200 shares were just downgraded
-
Business11 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General9 hours agoFatal house fire at Lake Illawarra under police investigation
-
Business12 hours agoAfter falling more than 20% on its FY25 result, are Inghams shares a buy the dip opportunity?